Copenhagen-based EvodiaBio raises €6 million to scale fermentation-based flavour technology

Danish flavour business EvodiaBio has actually increased EUR6 million (DKK 45 million) in a brand-new financing round to increase development in existing markets and sustain their growth right into the oriental market.

The round was led by the American investment company RA Resources Monitoring’s Planetary Wellness Fund and signed up with by various other brand-new capitalists Wild Radicals and Francis Household Finances, in addition to existing capitalists EIFO, Ananke Ventures, Newtree Influence, PINC (Paulig), Jarne Elleholm (founder and Chairman of the Board), Sotirios Kampranis (founder), Camilla Kloss Fenneberg (CHIEF EXECUTIVE OFFICER), and 3 board participants: Flemming Besenbacher, Anne Cabotin, and Andreas Fibig.

Today’s financing news, adheres to last year’s €7 million raise – as reported by EU-Startups

” I boast of our group– within simply 3 and a fifty percent years, we have actually gone from a research study task to commercial manufacturing with all essential authorizations and a rewarding item. That is hardly ever seen in the BioTech market. This financial investment allows us to increase worldwide development and know our passion of coming to be a leader in commercial BioTech, claims Camilla Fenneberg, Chief Executive Officer of EvodiaBio.

In 2025, EU-Startups reporting indicate ongoing financier passion in fermentation-based and lasting BioTech, supplying a valuable context for EvodiaBio’s brand-new round.

French start-up Fungu’it increased EUR4 million to create all-natural flavourings making use of fungis fermentation, highlighting need for different scent and preference options with reduced ecological effect. In a nearby application location, Swedish precision-fermentation business Melt&Marble safeguarded EUR7.3 million to scale its developer fats for food and appeal, while German start-up Kynda increased EUR3 million to broaden lasting fungal healthy protein manufacturing.

Taken with each other, these 2025 rounds total up to roughly EUR14.3 million spent throughout flavour, active ingredient and fermentation-driven BioTech in Europe.

Versus this background, EvodiaBio’s EUR6 million raising placements it within a wider, data-supported pattern of resources streaming right into commercial BioTech systems that use fermentation to food and drink worth chains, with its particular concentrate on yeast-derived all-natural fragrances matching nearby growths in flavours, fats and healthy proteins.

” RA Resources’s financial investment in EvodiaBio at this phase highlights the business’s solid setting. It validates that we have actually gotten rid of the vital dangers connected to innovation, manufacturing, and commercialisation. We have actually confirmed that the innovation functions, that consumers have an interest in the item, which business design has actually paid from the first day. Currently we prepare to increase development, claims Jarne Elleholm, Chairman of the Board at EvodiaBio.

He includes:” What EvodiaBio has actually accomplished in document time is very uncommon in our market. Relocating from the lab to a total manufacturing system, worldwide collaborations, and market passion in such a brief time shows that Denmark has the possible to come to be a leading center for biosolutions. The brand-new resources enables us to increase also additional and demonstrate how much commercial BioTech can take Denmark.”

Established In 2021, EvodiaBio is a commercial BioTech business that creates lasting fragrances via fermentation. The innovation is utilized readily in the drink market and makes it possible for the manufacturing of all-natural fragrances with substantially reduced source usage and carbon monoxide two discharges than typical approaches.

In simply over 3 years, EvodiaBio has actually relocated from the lab to commercial manufacturing of yeast-derived all-natural monoterpenes.

Given that the launch of its Yops innovation system previously this year, EvodiaBio has actually accomplished worldwide business grip with greater than 70 business mixtures and over 10 jobs with top-40 breweries worldwide.

“ EvodiaBio’s innovation system well fixes the issue of effectively and sustainably generating all-natural fragrances at commercial range. The group has actually performed with a rate and resources effectiveness hardly ever seen in BioTech,” claims Kyle Teamey, Taking Care Of Companion at RA Resources.

Teamey includes: “ We see terrific possible in the business’s network collaborations with Symrise and Lallemand and we are thrilled to sustain the business as it ranges globally and increases right into brand-new sections.”

With its most recent financial investment and solid collaborations, EvodiaBio is well placed to increase its development. The following actions consist of growth right into brand-new markets such as Asia and using its lasting innovation throughout added markets, consisting of various other drinks, white wine, and the scent market extra generally.

This most recent financing round is the business’s 3rd in 3 years. In overall, EvodiaBio has actually increased EUR20 million (DKK 150 million).

” This financial investment positions us in a solid setting to increase our development and broaden our innovation right into brand-new markets, specifically in Asia. We have actually accomplished solid business recognition, yet we are still early in our development trip. Our objective is to come to be a worldwide leader in commercial biotech, and we see a remarkable chance to go into numerous markets with our lasting and effective options,” includes Fenneberg

The blog post Copenhagen-based EvodiaBio raises €6 million to scale fermentation-based flavour technology showed up initially on EU-Startups.